These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9782219)
41. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021 [TBL] [Abstract][Full Text] [Related]
42. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. Kim YH; Oh SH; Kim JS J Bone Joint Surg Br; 2003 Jul; 85(5):661-5. PubMed ID: 12892186 [TBL] [Abstract][Full Text] [Related]
43. Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement. Torigoshi T; Motokawa S; Maeda Y; Maeda K; Hiura T; Takayama G; Taguchi K; Shindo H; Migita K BMC Musculoskelet Disord; 2009 Apr; 10():42. PubMed ID: 19397833 [TBL] [Abstract][Full Text] [Related]
44. The safety and efficacy of intraoperative heparin in total hip arthroplasty. DiGiovanni CW; Restrepo A; González Della Valle AG; Sharrock NE; McCabe JP; Sculco TP; Pellicci PM; Salvati EA Clin Orthop Relat Res; 2000 Oct; (379):178-85. PubMed ID: 11039805 [TBL] [Abstract][Full Text] [Related]
45. Assessment of 30-day mortality and complication rates associated with extended deep vein thrombosis prophylaxis following hip fracture surgery. Durand WM; Goodman AD; Johnson JP; Daniels AH Injury; 2018 Jun; 49(6):1141-1148. PubMed ID: 29580646 [TBL] [Abstract][Full Text] [Related]
46. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587 [TBL] [Abstract][Full Text] [Related]
47. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study. Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317 [TBL] [Abstract][Full Text] [Related]
48. Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean? Cohen AT; Khushal A Haemostasis; 2000; 30 Suppl 2():88-94; discussion 82-3. PubMed ID: 11251349 [TBL] [Abstract][Full Text] [Related]
49. Combination prophylaxis versus pharmacologic prophylaxis alone for preventing deep vein thrombosis in hip surgery. Lin FF; Lin CH; Chen B; Zheng K Hip Int; 2016 Nov; 26(6):561-566. PubMed ID: 27739569 [TBL] [Abstract][Full Text] [Related]
50. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Miric A; Lombardi P; Sculco TP Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014 [TBL] [Abstract][Full Text] [Related]
51. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty. Whang PG; Lieberman JR Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893 [TBL] [Abstract][Full Text] [Related]
52. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty]. Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980 [TBL] [Abstract][Full Text] [Related]
53. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group. Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367 [TBL] [Abstract][Full Text] [Related]
54. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries. Amin AN; Lin J; Thompson S; Wiederkehr D Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717 [TBL] [Abstract][Full Text] [Related]
55. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588 [TBL] [Abstract][Full Text] [Related]
56. Incidence and prevention of thromboembolic events in one stage bilateral total hip arthroplasty: a systematic review. Babis GC; Sakellariou VI; Johnson EO; Soucacos PN Curr Vasc Pharmacol; 2011 Jan; 9(1):24-32. PubMed ID: 21044027 [TBL] [Abstract][Full Text] [Related]
57. Intermittent pneumatic compression stocking prophylaxis against deep venous thrombosis in anterior cervical spinal surgery: a prospective efficacy study in 200 patients and literature review. Epstein NE Spine (Phila Pa 1976); 2005 Nov; 30(22):2538-43. PubMed ID: 16284592 [TBL] [Abstract][Full Text] [Related]
58. Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin. Lastória S; Rollo HA; Yoshida WB; Giannini M; Moura R; Maffei FH Acta Cir Bras; 2006; 21(3):184-6. PubMed ID: 16751933 [TBL] [Abstract][Full Text] [Related]
59. A randomized, prospective trial of deep venous thrombosis prophylaxis in aortic surgery. Killewich LA; Aswad MA; Sandager GP; Lilly MP; Flinn WR Arch Surg; 1997 May; 132(5):499-504. PubMed ID: 9161392 [TBL] [Abstract][Full Text] [Related]
60. Deep Vein Thrombosis Prophylaxis in the Neurosurgical Patient. Shaikhouni A; Baum J; Lonser RR Neurosurg Clin N Am; 2018 Oct; 29(4):567-574. PubMed ID: 30223969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]